Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for Myopic Choroidal Neovascularization
NCT01246089Phase 4Unknown
- Sponsor
- Instituto de Olhos de Goiânia
- Start
- Jul 2009
- Primary completion
- Oct 2014
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in choroidal neovascularization (CNV), sponsored by Instituto de Olhos de Goiânia. Status: unknown.
02
Drugs
ranibizumab
03
Conditions
choroidal neovascularization (CNV)
Beyond the preview
Go deeper on NCT01246089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01246089.